Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy

Ruoxi Zhao,Yanlin Zhu,Lili Feng,Bin Liu,Yaoyu Hu,Haixia Zhu,Zhiyu Zhao,He Ding,Shili Gai,Piaoping Yang
DOI: https://doi.org/10.1002/adma.202307115
IF: 29.4
2023-09-23
Advanced Materials
Abstract:Taking the significance of the special microenvironment for tumor cell survival into account, disrupting tumor redox homeostasis is highly prospective for improving therapeutic efficacy. Herein, a multifunctional two‐dimensional vanadium‐based MXene nanoplatform, V4C3/atovaquone@bovine albumin (V4C3/ATO@BSA, abbreviated as VAB) has been elaborately constructed for ATO‐enhanced nanozyme catalytic/photothermal therapy. The redox homeostasis within the tumor cells has eventually been disrupted, showing a remarkable anti‐tumor effect. The VAB nanoplatform with mixed vanadium valence states can induce a cascade of catalyzed reactions in the tumor microenvironment, generating plenty of reactive oxygen species (ROS) with effective glutathione consumption to amplify oxidative stress. Meanwhile, the stable and strong photothermal effect of VAB under near‐infrared irradiation not only causes the necrosis of tumor cells but also improves its peroxidase‐like activity. In addition, the release of ATO can effectively alleviate endogenous oxygen consumption to limit triphosadenine formation and inhibit mitochondrial respiration. As a result, the expression of heat shock proteins is effectively suppressed to overcome thermoresistance and the production of ROS can be further promoted due to mitochondrial injury. Moreover, VAB also presents high photoacoustic and photothermal imaging performances. In brief, the multifunctional nanoplatform can provide ATO‐enhanced nanozyme catalytic/photothermal therapy with broadening the biomedical applications of vanadium‐based MXene. This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?
The paper aims to address several key issues in tumor treatment, particularly by disrupting the redox homeostasis within tumor cells to enhance therapeutic efficacy. Specifically, the paper constructs a multifunctional 2D nanoplatform based on vanadium-based MXene (V4C3/atovaquone@bovine serum albumin, abbreviated as VAB) to enhance nanozyme catalysis/photothermal therapy. The main issues the paper attempts to address are as follows: 1. **Enhancing Tumor Treatment Efficacy**: By disrupting the redox balance within tumor cells, increasing oxidative stress, and thereby achieving significant anti-tumor effects. 2. **Overcoming Tumor Thermoresistance**: Tumor cells typically have higher thermoresistance compared to normal cells, which limits the effectiveness of photothermal therapy. The proposed method can inhibit the expression of heat shock proteins (HSPs), thereby overcoming the thermoresistance of tumor cells. 3. **Alleviating Tumor Hypoxia**: Tumor tissues are usually in a hypoxic state, which promotes the proliferation and metastasis of tumor cells and hinders oxygen-dependent therapeutic methods. VAB can alleviate tumor hypoxia by reducing intracellular oxygen consumption, further enhancing therapeutic efficacy. 4. **Improving Stability and Biocompatibility of Nanomaterials**: Traditional nanomaterials are often unstable within biological systems, affecting their therapeutic efficacy. VAB improves the stability and biocompatibility of nanomaterials by using bovine serum albumin (BSA) as a carrier. 5. **Achieving Multimodal Imaging and Therapy**: VAB not only has efficient photothermal conversion performance but can also be used for photoacoustic imaging and photothermal imaging, thereby enabling real-time monitoring and treatment of tumor sites. In summary, by designing and constructing the VAB nanoplatform, the paper aims to enhance tumor treatment efficacy through multiple synergistic mechanisms and overcome the limitations of existing therapeutic methods.